A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus
Andrew Young(The University of Queensland), Keith J. Chappell(Australian Research Council), Daniel Watterson(The University of Queensland), Nicolas Tardiota(The University of Queensland), Rhiannon L. Dalrymple(The University of Queensland), Robert McCuaig(University of Canberra), Noushin Jaberolansar(The University of Queensland), J.L. Dutton(The University of Queensland), Emmanuel Hanon(Institut des Arts de Diffusion), Tim Webb(The University of Queensland), Paul R. Young(Kent State University), Juana Magdalena(Institut des Arts de Diffusion), Naphak Modhiran(The University of Queensland), Sharada Kolekar(The University of Queensland), Carlos Alvarez-Mendoza(The University of Queensland), Varsha Kommajosyula(The University of Queensland), Quimbe Dy(The University of Queensland), Frank Vandendriessche(Institut des Arts de Diffusion), Marianne Gillard(The University of Queensland), Jean Smal(Institut des Arts de Diffusion), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation)
Cited by 8
Related Papers
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
|Molecular Psychiatry|2022|178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
|Nature Communications|2021|177
Detection of dengue virus in saliva and urine by real time RT-PCR
|Virology Journal|2010|134